The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
IMO the SP should be around 14p even after using a fully diluted (including all warrants and loans) 200m for the number of shares, using 2015 profit of £2.3m and a market sector average of 13. But as always please Do Your Own Research ("DYOR") and please check my calculations. Something else worth considering is that the Directors may of course wish to defer the date of maturity on the loans with a reduced rate of interest as JM and SR did on 26 February 2015 but again please DYOR.
Your an idiot if you dont sell sou imo. What pile of overvalued crap. Do the ACTUAL maths here imo. 20p MINIMUM. (I HOPE YOU SELL OUT FOR 20% YOU TWAT)
I hold here, and I've just read, and replied, to your post on SOU. You are an idiot. I'm expecting decent results here, and will amazed if we spike +20%, as for 20p, you are an idiot, and I'm being kind. Korg, do not approach buy button, keep well clear, take advise from elders, and remember, your wealth is at stake.
this SO undervalued its an fffing joke. Market is just asleep on this one. Wait for results imo. 20p MINIMUM
Last time I did not like the quality of some of the loan books but I liked the number of shares in issue. Last figures were good and brexit had little effect.So expecting a set of decent numbers despite reservations over past dealings with third party loan books which may set off bad loans even though I think they were well covered for default There is also a remote possibility of a bigger fish taking an interest here.
Should deliver £2million profit, possibly more. Make this look a VERY cheap share.
Consumer confidence rebounds as figures ease post-Brexit vote nerve https://www.theguardian.com/business/2016/aug/31/uk-consumer-confidence-rebounds-post-brexit-vote-figures
Looks like business has been good Pound Higher As U.K. Consumer Credit, Business Lending Improves http://www.rttnews.com/2686035/pound-higher-as-u-k-consumer-credit-business-lending-improves.aspx
starting the run up to results. Could be another record year imo with even stronger outlook. SP should be on the 20s plus.
These seem late compared to last year, when I rang the company I was told should be within the next two weeks. I hope no nasty surprises. The share price seems to remain stubbornly low for a company posting results as it has to date. It is however adversely affected by the number of warrants and options the controlling interests have granted themselves at very advantageous prices!
"Next interim announcement (E) September 2016" http://www.mfg.im/irhome
Interims next week - forecasting steady progress/growth and another £1million+ profit to add to their cash pile which is almost the same as the market cap! Seriously undervalued
https://www.conisterbank.co.im/news/conister-bank-continues-expand/ Interim results 18 August (E)
announces six appointments as part of growth strategy http://www.edgewater.co.im/news/ "With an annual adjusted return on equity of 18% and a fully developed back office offering, this market sector is one I am keen on investing further in." Chairmans statement 29/2/16
jolly, you are so wrong on this one. Wait for the next update. youll see how undervalued this.
freddy.. ...chin up...just another dud ....may be worth a punt down where Jim swims (2-4p)??
cheap as chips if Jim doesn't issue more warrants/convertibles..or extend maturity
Jolly, do you not think that even fully diluted with all the Jim Mellon stuff this is still good value? Todays RNS is good news, the outlook from the full year was bullish. Compare this to most AIM 10mill MCap companies and its impressive, no?
convert and hold ords only
IMO the SP should be around 14p even after using a fully diluted (including all warrants and loans) 200m for the number of shares, using 2015 profit of £2.3m and a market sector average of 13. But as always please Do Your Own Research ("DYOR") and please check my calculations. Something else worth considering is that the Directors may of course wish to defer the date of maturity on the loans with a reduced rate of interest as JM and SR did on 26 February 2015 but again please DYOR.
As in .. resign, donate his toupe to medical science! What?
thing, then it may be investible
So, at what price, or how much profit would make it become unchallenged? Or will it never pass the jolly test.
but mfx has its challenging capital structure
Times are changing for banks. Tipped to rocket after brexit.